Regulation of the human menstrual cycle

Frontiers in Neuroendocrinology

Volumn 19, Issue 3, 1998, Pages 151-186

  Buffet, N Chabbert ^a   Djakoure, C ^a   Maitre, S Christin ^a   Bouchard, P ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Atresia; Endometrial cycle; Estradiol; FSH; Hypothalamopituitary axis; Implantation; Inhibin; LH; Ovary; Paracrine; Progesterone

Indexed keywords

HORMONAL REGULATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMPLANTATION; MENSTRUAL CYCLE; OOCYTE DEVELOPMENT; PRIORITY JOURNAL; REVIEW;

EID: 0031848271     PISSN: 00913022     EISSN: None     Source Type: Journal    
DOI: 10.1006/frne.1998.0167     Document Type: Article

References (181)

1. Adams JM, Taylor AE, Schoenfeld DA, Crowley WF Jr, Hall JE. The midcycle gonadotropin surge in normal women occurs in the face of an unchanging gonadotropin releasing hormone pulse frequency. J Clin Endocrinol Metab 1994; 79: 858-864.
2. Aittomäki K, Dieguez-Lucena JL, Parkarinen P, Sistonen P, Tapanainen J, Gromoll J, Kaskikari R, Sankila E-M, Nieschlag E, Huhtaniemi I, de la Chapelle A. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995; 82: 959-968.
3. Aittomäki K, Herva R, Stenman UH, Juntunen K, Ylostalo P, Hovatta O, de la Chapelle A. Clinical features of primary ovarian failure caused by a point mutation in the follicle- stimulating hormone receptor gene. J Clin Endocrinol Metab 1996; 81: 3722-3726.
4. Amso NN, Crow J, Shaw RW. Comparative immunohistochemical study of estrogen and progesterone receptors in the fallopian tubes and uterus at different stages of the menstrual cycle and the menopause. Hum Reprod 1994; 9: 1027-1037.
5. Baker J, Hardy MP, Zhou J, Bondy C, Lupu F, Bellve AR, Efstratiadis A. Effects of an IgfI null mutation on mouse reproduction. Mol Endocrinol 1996; 10: 903-918.
6. Balash J, Miro F, Burzaco I. The role of luteinizing hormone in human follicle development and oocyte fertility: Evidence from in-vitro fertilization in a woman with long-standing hypogonadotropic hypogonadism and using recombinant human follicle stimulating hormone. Human Reprod 1995; 10: 1678-1683.
7. Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Kuttenn F, Nihoul Fekete C, Souleyreau- Therville N, Thibaud E, Fellous M, McElreavy K. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nature Genet 1997; 17: 467-470.
8. Berchuck A, Soisson AP, Soper JT, Clarke-Pearson DL, Bat RC Jr, McCarty KS Jr. Reactivity of epidermal growth factor receptor monoclonal antibodies with human uterine tissues. Arch Pathol Lab Med 1989; 113: 1155-1158.
9. Bergeron C, Ferenczy A, Shyamala G. Distribution of oestrogen receptors in various cell types of normal, hyperplastic and neoplastic human endometrial tissues. Lab Invest 1988; 58: 338-344.
10. Bergeron C, Ferenczy A, Toft DO, Schneider W, Shyamala G. Immunocytochemical study of progesterone receptors in the human endometrium during the menstrual cycle. Lab Invest 1988; 59: 862-869.
11. Besnard N, Pisselet C, Monniaux D, Locatelli A, Benne F, Gasser F, Hatey F, Monget P. Expression of messenger ribonucleic acids of insulin-like growth factor binding protein-2, -4, and -5 in the ovine ovary: Localization and changes during growth and atresia of antral follicles. Biol Reprod 1996; 55: 1356-1367.
12. Bose HS, Pecvitz OH, Miller WL. Spontaneous feminization in a 46,XX female patient with congenital lipoid adrenal hyperplasia due to a homozygous frameshift mutation in the steroidogenic acute regulatory protein. J Clin Endocrinol Metab 1997; 82:1511-1515.
13. Bose HS, Sugawara T, Strauss JF III, Miller WL. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N Engl J Med 1996; 335: 1870-1878.
14. Boulton MI, McGrath TJ, Goode JA, Broad KD, Gilbert CL. Changes in content of mRNA encoding oxytocin in the pig uterus during the oestrus cycle, pregnancy, at parturition, and in lactational anoestrus. J Reprod Fertil 1996; 108: 219-227.
15. Braun T, Schofield PR, Sprengel R. Amino-terminal leucine-rich repeats in gonadotropin receptors determine hormone selectivity. EMBO J 1991; 10: 1885-1890.
16. Bulun SE, Mahendroo MS, Simpson ER. Polymerase chain reaction amplification fails to detect aromatase cytochrome P450 transcripts in normal human endometrium or decidua. J Clin Endocrinol Metab 1993; 76: 1458-1463.
17. Byers M, Kuiper GGJ, Gustaffson JA, Park Sage OK. estradiol receptor b mRNA expression in the rat ovary. Down regulation by gonadotropins. Mol Endocrinol 1997; 11:172-182.
18. Catt KJ, Pierce JG. Gonadotropin hormones of the adenohypophysis. In: Yen SSC, Jaffe RB, Eds. Reproductive Endocrinology. Philadelphia: Saunders, 1986: 75-114.
19. Chandrasekher YA, Hutchison JS, Zelinsky-Wooten MB, Hess DL, Wolf DP, Stouffer RL. Initiation of periovulatory events in primate follicle using recombinant and native human luteinizing hormone to mimic the midcycle gonadotropin surge. J Clin Endocrinol Metab 1994; 79: 298-306.
20. Chang RJ, Jaffe RB. Progesterone effects on gonadotropin release in women pretreated with estradiol. J Clin Endocrinol Metab 1978; 47: 119-125.
21. Clark BJ, Wells J, King R, Stocco DM. The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells: Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem 1994; 269: 28314-28322.
22. Clarke IJ. The preovulatory LH surge. A case of a neuroendocrine switch. Trends Endocrinol Metab 1995; 6: 241-247.
23. Collins R, Hodgen G. Blockade of the spontaneous midcycle gonadotropin surge in monkeys by RU 486: A progesterone antagonist or agonist? J Clin Endocrinol Metab 1986; 63: 1270-1276.
24. Combarnous Y. Mécanismes d'action des médiateurs à récepteurs membranaires. In: Biochimie des communications cellulaires, Combarnous Y Ed. Lavoisier TEC&DOC. Editions Médicales Internationales, Paris 1996:74.
25. Couzinet B, Lestrat N, Brailly S, Forest M, Schaison G. Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency. J Clin Endocrinol Metab 1988; 66: 552-556.
26. de Ziegler D, Bergeron C, Cornel C, Medalie DA, Massai MR, Milgrom E, Frydman R, Bouchard P. Effects of luteal estradiol on the secretory transformations of human endometrium and plasma gonadotropins. J Clin Endocrinol Metab 1992; 74: 321-331.
27. Dong JW, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM. Growth differentiation factor 9 is required during early ovarian folliculogenesis. Nature 1996; 383: 531-535.
28. Dor J, Ben Shlomo I, Lunenfeld B, Pariente C, Levran D, Karasik A, Seppälä M, Mashiach S. Insulin-like growth factor-I may not be essential for ovarian follicular development: Evidence from IGF-I deficiency. J Clin Endocrinol Metab 1992; 74: 539-542.
29. Drummond IA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher FJ III. Repression of the insulin-like growth factor II gene by the Wilm's tumor suppressor WT1. Science 1992; 257: 674-678.
30. Dubourdieu S, Charbonnel B, d'Acremont MF, Carreau S, Spitz IM, Bouchard P. Effect of administration of a GnRH antagonist (Nal-Glu) during the preovulatory period: The LH surge requires secretion of GnRH. J Clin Endocrinol Metab 1994; 78: 343-347.
31. Dubourdieu S, Charbonnel B, Massai MR, Marraou J, Spitz IM, Bouchard P. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: Effect of the dose and timing of human chorionic gonadotropin administration. Fertil Steril 1991; 56: 440-445.
32. Dufau ML. The luteinizing hormone receptor. Curr Opin Endocrinol Diabetes 1995; 2: 365-374.
33. Duffy DM, Hutchison JS, Stewart DR, Stouffer RL. Stimulation of primate luteal function by recombinant human chorionic gonadotropin and modukation of steroid, but not relaxin, production by an inhibitor of 3 beta-hydroxysteroid dehydrogenase during stimulated early pregnancy. J Clin Endocrinol Metab 1996; 81: 2307-2313.
34. El Roeiy A, Chen X, Roberts VJ, LeRoith D, Roberts CT, Yen SSC. Expression of insulin-like growth factor-I (IGF-I) and IGF-II and the IGF-I, IGF-II, and insulin receptor genes and localization of the gene products in the human ovary. J Clin Endocrinol Metab 1993; 77: 1411-1418.
35. Erickson GF. Defining apoptosis: Players and systems. J Soc Gynecol Invest 1997; 4: 219-227.
36. Ezoe K, Holmes SA, Ho LL, Bennett CP, Bolognia JL, Brueton L, Burn J, Falabella R, Gatto EM, Ishii N. Novel mutations and deletions of the kit (Steel Factor-receptor) gene in human piebaldism. Am J Hum Genet 1995; 56: 58-66.
37. Fauser BCJM, van Heudsen AM. Manipulation of human ovarian function: Physiological concepts and clinical consequences. Endocrin Rev 1997; 18: 71-106.
38. Ferenczy A, Bergeron C. Histology of the human endometrium: From birth to senescence. In: Bulletti C, Gurpide E, Eds. The Primate Endometrium, Annals of the New York Academy of Sciences. New York: NY Academy of Sciences, 1991; 6-27.
39. Ferenczy A, Guralnick M. Endometrial microstructure: Structure-function relationships throughout the menstrual cycle. Semin Reprod Endocrinol 1983; 1-205.
40. Ferenczy A. Anatomy and histology of the cervix. In: Kurman R, Eds. Blaunstein's Pathology of the Female Genital Tract. 4th ed. New York: Springer-Verlag, 1994: 185-201.
41. Ferenczy A. Regeneration of the human endometrium. In: Fenoglio CM, Wolff M, Eds. Progress in Surgical Pathology. New York: Masson, 1980: 157-173.
42. Findlay JK. An update on the roles of inhibin, activin and follistatin as local regulators of folliculogenesis. Biol Reprod 1993; 48: 15-23.
43. Fitzpatrick RL, Liggins GC. Effects of prostaglandins on the cervix of pregnant women and sheep. In: Naftolin F, Stubbelfield PF, Eds. Dilatation of the Uterine Cervix. New York: Raven Press, 1980: 287-300.
44. Franks S. Medical progress article: Polycystic ovary syndrome. N Engl J Med 1995; 333: 853-861.
45. Fraser HM, Bouchard P. Control of the preovulatory luteinizing hormone surge by gonadotropin releasing hormone antagonists. Prospects for clinical application. Trends Endocrinol Metab 1994; 5: 87-93.
46. Fraser HM, Lunn SF. Does inhibin have an endocrine function during the menstrual cycle. Trends Endocrinol Metab 1993; 4: 187-194.
47. Fujieda K, Tajima T, Nakae J, Sageshima S, Tachibana K, Suwa S, Sugawara T, Strauss JF 3rd. Spontaneous puberty in 46,XX subjects with congenital lipoid adrenal hyperplasia. Ovarian steroidogenesis is spared to some extent despite inactivating mutations in the steroidogenic acute regulatory protein(StAR) gene. J Clin Invest 1997; 99:1265-1271.
48. Furui K, Suganuma N, Tsukahara S-I, Asada Y, Kikkawa F, Tanaka M, Ozwa T, Tomoda Y Identification of two point mutations in the gene coding luteinizing hormone (LH) β-subunit, associated with immunologically anormalous LH variants. J Clin Endocrinol Metab 1994; 78: 107-113.
49. Galway AB, Lapolt PS, Tsafriri A, Dargam CM, Boime I, Hsueh AJW. Recombinant follicle- stimulating hormone induces ovulation and tissue plasminogen activator expression in hypophysectomized rats. Endocrinology 1990; 127: 3023-3028.
50. Garcia E, Bouchard P, De Brux J, Berdah J, Frydman R, Schaison G, Milgrom E, Perrot- Applanat M. Use of the immunocytochemistry of progesterone and oestrogen receptors for endometrial dating. J Clin Endocrinol Metab 1988; 67: 80-87.
51. Gharib SD, Wierman ME, Shupnik MA, Chin WW. Molecular biology of the pituitary gonadotropins. Endocin Rev 1990; 11: 177-199.
52. Giudice LC. Growth factors and growth modulators in human uterine endometrium: Their potential relevance to reproductive medecine. Fertil Steril 1994; 61: 1-17.
53. Gordon JD, Mesiano S, Zaloudeck CJ, Jaffe RB. Vascular endothelial growth factor localization in human ovary and fallopian tubes: Possible role in reproductive function and ovarian cyst formation. J Clin Endocrinol Metab 1996; 81: 353-359.
54. Gosden RG. The causes and consequences of ovarian ageing. In: Biology of Menopause. Academic Press, London 1985.
55. Gospadorowicz D, Bialecki H. Fibroblast and epidermal growth factors are mitogenic for cultured granulosa cells of rodent, porcine, and human origin. Endocrinology 1979; 104: 757-764.
56. Gougeon A. Dynamics of human follicular growth. In: Adashi EY, Leung PCK Eds. The Ovary. Raven Press New York 1993: 21-39.
57. GougeonA. Regulation of ovarian follicular development in primates: Facts and hypotheses. Endocrin Rev 1996; 17: 121-155.
58. Gromoll J, Ried T, Holtgreve-grez H, Nieschlag E, Gudermann T. Localization of the human FSH receptor to chromosome 2p21 using a genomic probe comprising exon 10. J Mol Endocrinol 1994; 12: 265-271.
59. Groome NP, Illingworth PJ, O'Brien M, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mather JP, McNeilly AS. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 1996; 81: 1401-1405.
60. Groome NP, O'Brien M. Immunoassays for inhibin and its subunits: Further applications of the synthetic peptide approach. J Immunol Methods 1993; 165: 176-176.
61. 2+ mobilization. Studies with the cloned murine luteinizing hormone receptor expressed in L cells. J Biol Chem 1992; 267: 4479-4488.
62. Havrilesky LJ, Hurteau JA, Whitaker RS, Elbendary A, Wu S, Rodriguez GC, Bast RC Jr, Berchuck A. Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor beta. Cancer Res 1995; 55: 944-948.
63. Hernandez ER, Hurwitz A, Vera A, Pellicer A, Adashi EY, Le Roith D, Roberts CT Jr. Expression of the genes encoding the insulin-like growth factors and their receptors in the human ovary. J Clin Endocrinol Metab 1992; 74: 419-426.
64. Hibbert ML, Stouffer RL, Wolf DP, Zelinsky-Wooten MB. Midcycle administration of a progesterone synthesis inhibitor prevents ovulation in primates. Proc Natl Acad Sci USA 1996; 93: 1897-1901.
65. Hillier SG, Yong EL, Illingworth PI, Baird DT, Schwall RH, Mason AJ. Effects of recombinant inhibin on androgen secretion in cultured human thecal cells. Mol Cell Endocrinol 1991; 75: R1-R6.
66. Hillier SG. Hormonal control of folliculogenesis and luteinization. In: Findlay JK, ed. Molecular Biology of the Female Reproductive System. San Diego Academic Press 1994; 1-37.
67. Hsu SY, Kaipia A, McGee E, Lomeli M, Hsueh AJW. Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti- apoptotic Bcl-2 family members. Proc Natl Acad Sci USA 1997; 94: 12401-12406.
68. Hsu SY, Kubo M, Chun SY, Haluska FG, Housman DE, Hsueh AJW. Wilm's tumor protein WT1 as an ovarian transcription factor: decreases in expression during follicle development and repression of inhibin a gene promoter. Mol Endocrinol 1995; 9: 135-1366.
69. Hsueh AJW, Billig H, Tsafriri A. Ovarian follicle atresia: A hormonally controlled apoptotic process. Endocrin Rev 1994; 15: 707-724.
70. Hsueh AJW, Dahl KD, Vaughan J, Tucker E, Rivier J, Bardin CW, Vale W. Heterodimers and homodimers of inhibin subunits have different paracrine actions in modulation of luteinizing hormone stimulated androgen synthesis. Proc Natl Acad Sci USA 1987; 84: 5082-5086.
71. Huang JR, Bellino FL, Osawa Y, Tseng L. Immunologic identification of the aromatase enzyme system in human endometrium. J Steroid Biochem 1989; 33: 1043-1047.
72. Hurst BS, Zilberstein M, Chou JY, Litman B, Steffens J, Leslie KK. Estrogen receptors are present in human granulosa cells. J Clin Endocrinol Metab 1995; 80: 229-309.
73. Hurwitz A, Loukides J, Ricciarelli E, Botero L, Katz E, Mc Allister JM, Garcia JE, Rohan R, Adashi EY, Hernandez ER. The human intraovarian interleukin 1 (IL-1) system: Highly- compratimentalized and hormonally-dependent regulation of the genes encoding IL-1, its receptor, and its receptor antagonist. J Clin Endocrinol Metab 1992; 89: 1746-1754.
74. Hurwitz A, Ricciarelli E, Botero L, Rohan RM, Hernandez ER, Adashi EY Endocrine and autocrine-mediated of the rat (theca-interstitial) interleukin-1β gene expression: Gonadotropin-dependent preovulatory acquisition. Endocrinology 1991; 129: 3427-3429.
75. Ingamells S, Campbell IG, Anthony FW, Thomas EJ. Endometrial progesterone receptor expression during the human menstrual cycle. J Reprod Fertil 1996; 106: 33-38.
76. Irwin JC, Kirk D, King RJB, Gwatkin RBL, Sachs H, Navre M, Giudice LC. Human endometrial matrix metalloproteinase-2 (MMP-2): Hormonal regulation of stromal cell secretion and messanger RNA expression during the menstrual cycle and potential role as a menstrual proteinase. J Clin Invest 1996; 97: 438-447.
77. Iwai T, Nanbu Y, Iwai M, Taii S, Fujii S, Mori T. Immunohistochemical localization of oestrogen receptors and progesterone receptors in the human ovary throughout the menstrual cycle. Virchows Arch Pathol Anat Histopathol 1990; 417: 369-375.
78. Jameson JL, Lindell CM. Isolation and characterization of the human chorionic gonadotropin β subunit (CG β) gene cluster: Regulation of transcriptionally active CG β gene by cyclic AMP. Mol CellBiol 1988; 8: 5100-5107.
79. Kalra SP. Mandatory neuropeptide-steroid signaling for the preovulatory luteinizing hormone-releasing hormone discharge. Endocrin Rev 1993; 14: 507-538.
80. Kauma S, Matt D, Strom S, Eierman D, Turner T. Interleukin-1β, human leukocyte antigen LHA-DRa, and transforming growth factor-β expression in endometrium, placenta and placental membranes. Am J Obstet Gynecol 1990; 163: 130-137.
81. Kelton CA, Cheng SVY, Nugent NP, Schweickhardt RL, Rosenthal JL, Overton SA, Wands GD, Kuseja JB, Luchette CA, Chappel SC. The cloning of the human follicle stimulating hormone receptor and its expression in COS-7, CHO, and Y-1 cells. Mol Cell Endocrinol 1992; 89: 141-151.
82. Klauber N, Rohan RM, Flynn E, d'Amato RJ. Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470. Nature Med 1997; 3: 443-446.
83. Knobil E, Hotchkiss J. The menstrual cycle and its neuroendocrine control. In: Knobil E, Neill JD Eds. The Physiology of Reproduction, Vol. 2. New York, Raven Press 1988: 1971-1994.
84. Kokawa K, Shikone T, Nakano R. Apoptosis in the human uterine endometrium during the menstrual cycle. J Clin Endocrinol Metab 1996; 81: 4144-4147.
85. Koos RD. Potential relevance of angiogenic factors to ovarian physiology. Sem Reprod Endocrinol 1989; 7: 29-40.
86. Kosugi S, Vandop C, Geffner ME, Rabl W, Carel JC, Chaussain JL, Mori T, Merendina JJ Jr, Shenker A. Characterization of heterogenous mutations causing constitutive activation of the luteinizing hormone receptor in familial male precocious puberty. Hum Mol Genet 1995; 4: 183-188.
87. Kraaij R, Post M, Kremer A, Milgrom E, Epping W, Brunner HG, Grootegoed JA, Themmen APN. A missense mutation in the second transmembrane segment of the luteinizing hormone receptor causes familial male-limited precocious puberty. J Clin Endocrinol Metab 1995; 80: 3168-3172.
88. Kremer H, Mariman E, Otten BJ, Moll GW Jr, Stoelinga GB, Wit JM, Jansen M, Drop SL, Faers B, Ropers HH. Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Hum Mol Genet 1993; 2: 1779-1783.
89. Kuiper GGJM, Emark E, Pelto Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel estradiol receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996; 93: 5925-5930.
90. Kumar TR, Wang Y, Lu N, Matzuk MM. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nature Genet 1997; 15: 201-204.
91. Lala PK, Graham CH. Mechanisms of trophoblast invasiveness and their control: The role of proteases and protease inhibitors. Cancer Metastasis Rev 1990; 9: 369-379.
92. Latronico AC, Anasti J, Arnhold IJP, Mendonca BB, Bloise W, Castro M, Tsigos C, Chrousos GP. Brief report: Testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Engl J Med 1996; 331: 507-512.
93. Layman CL, Shelley ME, Huey LO, Wall SW, Tho SPT, McDonough PG. Follicle-stimulating hormone beta gene structure in premature ovarian failure. Fertil Steril 1993; 60: 852-857.
94. Le Nestour E, Marraoui J, Lahlou N, Roger M, de Ziegler D, Bouchard P. Role of estradiol in the rise in follicle-stimulating hormone levels during the luteal-follicular transition; J Clin Endocrinol Metab 1993; 77: 439-442.
95. Lessey BA, Damjanovich L, Coutifaris C, Castelbaum AJ, Albleda SM, Buck CA. Integrin adhesion molecules in the human endometrium. Correlation with the normal and abnormal menstrual cycles. J Clin Endocrinol Metab 1992; 90: 188-195.
96. Lessey BA, Killial AP, Metzger DA, Haney AF, Greene JL, McCarty KS. Immunohistochemical analysis of human uterine oestrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab 1988; 67: 334-340.
97. Lessey BA, Lei Y, Castelbaum AJ, Yowell CW, Buck CA, Sun J. Further characterization of endometrial integrins during the menstrual cycle and in pregnancy. Fertil Steril 1994; 62: 497-506.
98. Levy D, Christin Maitre S, Leroy I, Bergeron C, Garcia E, Freitas S, Coelingh-Bennink HJCB, Bouchard P. The endometrial approach in contraception. Ann NY Acad Sci 1997; 828: 59-83.
99. Leyendecker G, Wildt L, Hansmann M. Pregnancies following chronic intermittent (pulsatile) administration of GnRH by means of a portable pomp. A new approch to the treatment of hypothalamic amenorrhea. J Clin Endocrinol Metab 1980; 51: 1214-1216.
100. Liaw JJ, He JR, Barraclough CA. Tyrosine hydroxylase messenger ribonucleic acid levels increase in Al but not locus coeruleus noradrenergic neurons in proestrus rats but not in diestrous or androgen sterilized animals. JNeuroendocrinol 1992; 4: 599-607.
101. Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM, Dey SK. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 1997; 91:197-208.
102. Lustbader JW, Wu H, Birken S, Pollak S, Gawinowic Z, Kolks MA, Pound AM, Austen D, Hendrickson WA, Confield RE. The expression, characterization and crystallization of wild-type and selenomethionyl human chorionic gonadotropin. Endocrinology 1995; 136: 640-650.
103. Majumdar SS, Mikuma N, Ishwad PC, Winters SJ, Attardi BJ, Perera AD, Plant TM. Replacement with recombinant human inhibin immediately after orchidectomy in the hypophysiotropically clamped male Rhesus Monkey (Macaca mulatta) maintains follicle- stimulating hormone (FSH) secretion and FSHβ messenger ribonucleic acid levels at precastration values. Endocrinology 1995; 136: 1969-1977.
104. Martel D, Monier MN, Roche D, Psychoyos A. Hormonal dependence of pinopodes formation at the uterine luminal surface. Human Reprod 1991; 6: 597-603.
105. Martimbeau S, Tilly J. Physiological cell death in endocrine-dependent tissues: An ovarian perspective. Clin Endocrinol 1997; 46: 241-254.
106. Matikainen T, Ding YQ, Vergara M, Huhtaniemi I, Couzinet B, Schaison G. Differing response of plasma bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone to gonadotropin releasing hormone antagonist and agonist in post menopausal women. J Clin Endocrinol Metab 1992; 75: 820-825.
107. Matthews CH, Borgato S, Beck-Peccoz P, Adams M, Tone Y, Gambino G, Casagrande S, Tedeschini G, Bernedetti A, Chatterjee VKK. Primary amenorrhoea and infertility due to a mutation in the β-subunit of follicle-stimulating hormone. Nature Genet 1993; 5: 83-86.
108. Mc Grath SA, Esquela AF, Lee SJ. Oocyte specific expression of growth and differenciation factor 9. Mol Endocrinol 1995; 9: 131-136.
109. McFarland KC, Sprengel R, Phillips HS, Kohler M, Rosemblit N, Nickolics K, Segaloff DL, Seeburg PH. Luteotropin-chorionic gonadotropin receptor: An unusual member of the G protein-coupled receptor family. Science 1989; 245: 494-499.
110. Mendelson CR, Means GD, Mahendroo MS, Corbin CJ, Steinkampf MP, Graham-Lorence S, Simpson ER. Use of molecular probes to study regulation of aromatase cytochrome P-450. Biol Reprod 1990; 42: 1-10.
111. Minegishi T, Nakamura K, Takakura Y, Miyamoto K, Hasegawa Y, Ibuki Y, Igarashi. Cloning and sequencing of human LH/hCG receptor cDNA. Biochem Res Commun 1990; 172: 1049-1054.
112. Moenter SM, Caraty A, Locatelli A, Karsh FJ. Pattern of gonadotropin-releasing hormone (GnRH) secretion leading up to ovulation in the ewe: existence of a preovulatory GnRH surge. Endocrinology 1991; 129: 1175-1182.
113. Mohankumar PS, Thyagarajan S, Quadri SK. Correlation of catecholamine release in the medial preoptic area with proestrus surges of luteinizing hormone and prolactin. Endocrinology 1994; 135: 119-126.
114. Molskness TA, Woodruff TK, Hess DL, Dahl KD, Stouffer RL. Recombinant human Inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in Rhesus monkeys. J Clin Endocrinol Metab 1996; 81: 4002-4006.
115. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995; 80: 3689-3698.
116. Motro B, Bernstein A. Dynamic changes in ovarian c-kit and Steel expression during the estrous reproductive cycle. Dev Dynam 1993; 197: 69-79.
117. Mulheron GW, Bosert NL, Lapp JA, Walmer DK, Schomberg DW Human granulosa luteal and cumulus cells express transforming growth factors-beta type 1 and type 2 mRNA. J Clin Endocrinol Metab 1992; 74: 458-460.
118. Murphy LJ, Gong Y, Murphy LC. Growth factors in normal and malignant uterine tissue. Ann NY Acad Sci 1991; 622: 383-401.
119. Naftolin F, Mor G, Horvath TL, Luguin S, Fajer AB, Kohen F, Garcia-Segura LM. Synaptic remodeling in the arcuate nucleus during the estrous cycle is induced by estrogen and precedes the preovulatory gonadotropin surge. Endocrinology 1996; 137: 5576-5580.
120. Nikas G, Drakakis P, Loutradis D, Mara-Skoufari C, Koumantakis E, Michalas S, Psychoyos A. Uterine pinopodes as markers of the "nidation window" in cycling women receiving exogenous oestradiol and progesterone. Human Reprod 1995; 10: 1208-1213.
121. Nishizuka Y. The molecular heterogeneity of protein kinase C and its application for cellular regulation. Nature 1989; 334: 661-665.
122. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950; 1: 3-25.
123. Oktay K, Briggs D, Gosden RG. Ontogeny of follicle-stimulating hormone receptor gene expression in isolated human ovarian follicles. J Clin Endocrinol Metab 1997; 82: 3748-3751.
124. Pettersson K, Ding YQ, Huhtaniemi I. An immunologically anomalous luteinizing hormone variant in a healthy woman. J Clin Endocrinol Metab 1992; 74: 164-171.
125. Pierce JG, Parsons TF. Glycoprotein hormones: structure and function. Annu Rev Biochem 1981; 50: 465-495.
126. Piquette GN, Simon C, Danasouri Frances A, Polan ML. Gene regulation of interleukin-1 beta, interleukin-1 receptor type I, and plasminogen activator inhibitor-1 and -2 in human granulosa-luteal cells. Fertil Steril 1994; 62: 760-770.
127. Psychoyos A, Mandon P. Etude de la surface de l'epithelium utérin au microscope électronique à balayage. Observations chez la ratte au 4ème et 5ème jours de la gestation. CR Acad Sci Paris 1971; 272: 2723-2729.
128. Rabinovici J, Blankstein J, Goldman B, Rudak E, Dor Y, Pariente G, Geier A, Lunenfeld B, Marshiach S. In vitro fertilization and primary embryonic cleavage are possible in 17 alpha-hydroxylase deficiency despite extremely low intrafollicular 17 beta-estradiol. J Clin Endocrinol Metab 1989; 68: 693-697.
129. Ramasharma K, Li Ch. Human pituitary and placental hormones control insulin-like growth factor-II in human granulosa cells. Proc Natl Acad Sci USA 1987; 84: 2643-2647.
130. Ravn V, Bruun Rasmussen B, Hojholt L, Barfoed M, Heiberg I, Svenstrup B, Thorpe SM. Oestrogen and progesterone receptors in normal cycling endometrium as studied by endpoint titration. Cell Tissue Res 1993; 276: 419-428.
131. Richardson SJ, Senikas V, Nelson JF. Follicular depletion during the menopausal transition: Evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 1987; 65: 1231-1237.
132. Riddick DH, Kusmick WF. Decidua: A possible source of amniotic fluid prolactin. Am J Obst Gynecol 1977; 127: 187-190.
133. Rodgers WH, Osteen KG, Matrisian LM, Navre M, Giudice LC, Gorstein F. Expression and localization of matrilysin, a matrix metalloproteinase in human endometrium during the reproductive cycle. Am J Obstet Gynecol 1993; 168: 253-260.
134. Rousseau-Merk MF, Mirashi M, Atger M, Loosfelt H, Milgrom E, Berger R. Localization of the human LH (luteinizing hormone) receptor gene to chromosome 2p21. Cytogenet Cell Genet 1990; 54: 77-79.
135. Ryan RJ, Charlesworth MC, McCormick DJ, Milius RP, Kreutmann HT. The glycoprotein hormones: Recent studies on structure function relationships. FASEB J 1988; 11: 2661-2669.
136. Sarkar DK, Chiappa SA, Fink G, Sherwood NM. Gonadotropin-releasing hormone surge in pro-oetrus rats. Nature 1976; 264: 461-463.
137. Satyaswaroop PG, Wartell DJ, Mortel R. Distribution of progesterone receptor, estradiol dehydrogenase, and 20α-dihydroprogesterone dehydrogenase activities in human endometrial glands and stroma: Progesterone induction of steroid dehydrogenase activities in vitro is restricted to the glandular epithelium. Endocrinology 1982; 111: 743-750.
138. Sawai K, Matsuzaki N, Kameda T, Hashimoto K, Okada T, Shimoya K, Nobunaga T, Taga T, Kishimoto T, Saji F. Leukemia inhibitory factor produced at the fetomaternal interface stimulates chorionic gonadotropin production: Its possible implication during pregnancy, including implantation period. J Clin Endocrinol Metab 1995; 80: 1449-1456.
139. Schoot DC, Harlin J, Shoham Z, Mannaerts BMJL, Lahlou N, Bouchard P, Coelingh Benninck HJT, Fauser BCJM. Recombinant human follicle-stimulating hormone and ovarian response in gonadotropin-deficient women. Human Reprod 1994; 9: 1237-1242.
140. Schoot DC. Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women. Human Reprod 1995; 9: 1237-1242.
141. Schwartzman RA, Cidlowski JA. Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocr Rev 1993; 14: 133-151.
142. Segaloff DL, Ascoli M. The lutropin/choriogonadotropin receptor . . . 4 years later. Endocrine Rev 1993; 14: 324-347.
143. Shenker A, Laue L, Kosugi S, Merendino J Jr, Minegishi T, Culler G Jr. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 1993; 365: 652-654.
144. Shoham Z, Balen A, Patel A, Jacobs HS. Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulated hormone in hypogonadotropic hypogonadism patients. Fertil Steril 1991; 56: 1048-1053.
145. Shortle B, Dyrenfurth I, Ferin M. Effects of an antiprogesterone agent, RU 486 on the menstruel cycle of the Rhesus monkey. J Clin Endocrinol Metab 1983; 60: 731-735.
146. Shun SY, Billig H, Tilly J, Furuta I, Tsafriri A, Hsueh AJW. Gonadotropin suppression of apoptosis in cultured preovulatory follicles: Mediatory role of endogenous insulin-like growth factor-I. Endocrinology 1994; 135: 1845-1853.
147. Simoni M, Gromoll J, Nieschlag E. The follicle-stimulating hormone receptor: Biochemistry, molecular biology, physiology, and pathophysiology. Endocrine Rev 1997; 18: 739-773.
148. Sprengel R, Braun T, Nikolics K, Segaloff DL, Seeburg PH. The testicular receptor for follicle-stimulating hormone: Structure and functional expression of cloned cDNA. Mol Endocrinol 1990; 4: 525-530.
149. Stantson PG, Burgon PG, Hearn MT, Robertson DM. Structural and functional characterization of hFSH and hLH isoforms. Mol Cell Endocrinol 1996; 125: 133-141.
150. Stewart C, Kaspar P, Brunet LJ, Blatt H, Gadi I, Kontgen F, Abboudanzo SJ. Blastocyst implantation depends on maternal expression of leukemia inhibitor factor. Nature 1992; 359: 76-79.
151. Stouffer RL, Dahl KD, Hess DL, Woodruff TK, Mather JP, Molskness TA. Systemic and intraluteal infusion of inhibin Aor activin A in rhesus monkeys during the luteal phase of the menstrual cycle. Biol Reprod 1994; 50: 888-895.
152. Strauss JF III, Gurpide E. The endometrium: Regulation and dysfunction. In: Yen SCC, Jaffe RB Eds. Reproductive Endocrinology. Philadelphia: WB Saunders, 1991; 309-356.
153. Strickland S, Richards WG. Invasion of the trophoblast. Cell 1992; 71: 355-357.
154. Sugahara T, Pixley MR, Minami S, Perlas E, Ben Menahem D, Hsueh AJW, Boime I. Biosynthesis of a biologically active single peptide chain containing the human common alpha and chorionic gonadotropin beta subunits in tandem. Proc Natl Acad Sci USA 1995; 92: 2041-2045.
155. Suzuki T, Asano H, Kimura N. Immunohistochemical distribution of progesterone, androgen and oestrogen receptors in the human ovary during the menstrual cycle: Relationship to the expression steroidogenic enzymes. Human Reprod 1994; 9: 1589-1595.
156. Tabibzadeh S. Cytokines and the hypothalamic-pituitary-ovarian-endometrial axis. Hum Reprod 1994; 9: 947-967.
157. Tabibzadeh S. Evidence of T cell activation and potential cytokine action in human endometrium. J Endocrinol Metab 1990; 70: 437-443.
158. Talmadge K, Vamvakopoulos NC, Fiddes J. Evolution of the genes for the β subunits of human chorionic gonadotropin and luteinizing hormone. Nature 1984; 307: 37-40.
159. The European Recombinant Human LH Study Group. Recombinant human luteinizing hormone (r-hLH) to support recombinant human follicle-stimulating hormone (r-hFSH)- induced follicular development in LH and FSH deficient anovulatory women: A dose-finding study. J Clin Endocrinol Metab, 1998; 83.
160. Toledo SPA, Brunner HG, Kraaij R, Post M, Dahia PLM, Hayashida CY, Kremer H, Themmen APN. An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46, XX female. J Clin Endocrinol Metab 1996; 81: 3850-3854.
161. Tsafriri A, Chun SY, Reich R. Follicular rupture and ovulation. In: Adashi EY, Leung PCK Eds. The Ovary. Raven Press New York 1993: 227-244.
162. Tseng L, Mazella J. Cyclic changes of estradiol metabolic enzymes in human endometrium during the menstrual cycle. In: Kimball FA, Eds. The Endometrium. New York: SP Medical and Scientific Books, 1980; 211-226.
163. Udoff LC, Adashi EY Intraovarian growth factors and follicular development. Curr Opin Endocrinol Diabetes 1996; 3: 478-482.
164. Ulloa Aguirre A, Midgley AM, Beitins IZ, Padmanabhan V. Follicle stimulating isohormones : Characterization and physiological relevance. Endocr Rev 1995; 16: 765-787.
165. Vale W, Rivier J, Vaughan J, McClintock R, Corrigan A, Woo W, Karr D, Spriss J. Purification and characterization of an FSH releasing protein from porcine follicular fluid. Nature 1986; 321: 776-779.
166. Vinson GP, Saridogan E, Puddefoot JR, Djahanbakhch O. Tissue renin-angiotensin systems and reproduction. Human Reprod 1997; 12: 651-662.
167. Voutilainen R, Miller WI. Coordinate tropic hormone regulation of mRNAs for insulin-like growth factor II and the cholesterol side-chain-cleavage enzyme, P450 sec, in human steroidogenic tissues. Proc Natl Acad Sci USA 1987; 84:1590-1594.
168. Watkins PC, Eddy R, BeckAK, Vellucci V, Leveroen B, Tanzi RE, Guzella JF, Shows TB. DNA sequence and regional assignment of the FSH β subunit to the short arm of human chromosome 11. DNA 1987; 6: 205-212.
169. Weiss H, Axelrod L, Whitcomb RW, Harris PE, Crowley WF, Jameson JL. Hypogonadism caused by a single aminoacid substitution in the beta subunit of luteinizing hormone. N Engl J Med 1992; 326: 179-183.
170. Weissman G. Labilization and stabilization of lysosomes. Fed Proc 1964; 23: 1038.
171. Weston AM, Zelinsky-Wooten, Hutchinson JS, Stouffer RL, Wolf DP. Developmental potential of embryos produced by in-vitro fertilization from gonadotropin-releasing hormone antagonist-treated macaques stimulated with recombinant human follicle-stimulating hormone alone or in combination with luteinizing hormone. Human Reprod 1996; 11: 608-613.
172. Woodruff T, Lyon RJ, Hansen SE, Rice GC, Mather JP. Inhibin and activin locally regulate rat ovarian follicle genesis. Endocrinology 1990; 127: 3196-3205.
173. Wu H, Lustbader JW, Liu Y, Canfield RE, Hendrickson WA. Structure of human chorionic gonadotropin at 2.6 A resolution from MAD analysis of the selenomethionyl protein. Structure 1994; 2: 545-558.
174. Wu TJ, Wang L, Wan YY. Detection of oestrogen receptor messenger ribonucleic acid in human oocytes and cumulus-oocyte complexes using reverse transcriptase-polymerase chain reaction. Fertil Steril 1993; 59: 54-59.
175. Xia L, Van Vught D, Alston EJ, Luckhaus J, Ferin M. A surge in gonadotropin-releasing hormone accompanies the estradiol-induced gonadotropin surge in the rhesus monkey. Endocrinology 1992; 131: 2812-2820.
176. Xiao E, Xia-Zhang L, Shanen D, Ferin M. Tonic support of luteinizing hormone secretion by adrenal progesterone in the ovariectomized monkey replaced with midfollicular phase levels of estradiol. J Clin Endocrinol Metab 1997; 82: 2233-2238.
177. Yuan W, Giudice LC. Programmed cell death in human ovary is a function of follicle and corpus luteum status. J Clin Endocrinol Metab 1997; 82: 3148-3155.
178. Yun Mei Fung H, Ling Wong Y, Wu Shun Wong F, Scott Rogers M. Study of oestrogen and progesterone receptors in normal human endometrium during the menstrual cycle by immunocytochemical analysis. Gynecol Obstet Invest 1994; 38: 186-190.
179. Zeleznick AJ, Hutchinson J. Luteotropic actions of LH on the macaque corpus luteum. In: Stouffer RL Ed. The Primate Ovary. New York: Plenum; 1987: 163.
180. Zeleznick AJ, Hutcison JS, Schuler HM. Passive immunization with anti-estradiol antibodies during the luteal phase of the menstrual cycle potentiates the perimestrual rise in serum gonadotrophin concentration and stimulates follicular growth in Cynomolgus monkeys (Maccaca fascicularis). J Reprod Fertil 1987; 80: 403-410.
181. Zhou J, Bondy C. The anatomy of the human ovarian insulin-like growth factor system. Biol Reprod 1993; 48: 467-482.